Evolus (EOLS) Share-based Compensation (2017 - 2026)
Evolus (EOLS) reported Share-based Compensation of $5.1 million for Q1 2026, down 13.7% on a YoY basis from $5.9 million in Q1 2025, and down 0.6% quarter-over-quarter from $5.1 million in Q4 2025.
Evolus (EOLS) Share-based Compensation (2017 - 2026) Analysis & Trends
Evolus has reported Share-based Compensation for 10 years, with the latest figure at $5.1 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 13.7% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (down 13.92% YoY), and the FY2025 full-year result was $20.7 million, down 6.99% from the prior year.
- Share-based Compensation for Q1 2026 stood at $5.1 million, down from $5.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $6.2 million in Q4 2024, with the low at $2.4 million in Q4 2022.
- Historically, Share-based Compensation has averaged $4.4 million across 5 years, with a median of $4.6 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 86.1% — and 2025, when it decreased 22.41%.
- Evolus' Share-based Compensation stood at $2.4 million in 2022, then jumped by 82.3% to $4.4 million in 2023, then jumped by 40.35% to $6.2 million in 2024, then slipped by 16.59% to $5.1 million in 2025, then retreated by 0.6% to $5.1 million in 2026.
- The last three Share-based Compensation figures came in at $5.1 million (Q1 2026), $5.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | 5.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.12 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 5.22 Mn |
| Sep 30, 2024 | 5.22 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 4.40 Mn |
| Dec 31, 2023 | 4.40 Mn |